Rua Bioscience Ltd. (NZ:RUA)
:RUA
RUA Stock Chart & Stats
$0.03
<$0.01(3.45%)
―
--
Day’s Range― - ―
52-Week Range$0.02 - $0.06
Previous CloseN/A
VolumeN/A
Average Volume (3M)34.23K
Market Cap
$10.18M
Enterprise Value$7.65M
Total Cash (Recent Filing)$2.17M
Total Debt (Recent Filing)$1.84M
Price to Earnings (P/E)―
Beta1.96
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding339,441,700
10 Day Avg. Volume38,336
30 Day Avg. Volume34,227
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.99
Price to Sales (P/S)2.55
P/FCF Ratio-1.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Rua Bioscience Ltd. News
RUA FAQ
What was Rua Bioscience Ltd.’s price range in the past 12 months?
Rua Bioscience Ltd. lowest stock price was $0.02 and its highest was $0.06 in the past 12 months.
What is Rua Bioscience Ltd.’s market cap?
Rua Bioscience Ltd.’s market cap is $10.18M.
When is Rua Bioscience Ltd.’s upcoming earnings report date?
Rua Bioscience Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 77 days.
How were Rua Bioscience Ltd.’s earnings last quarter?
Rua Bioscience Ltd. released its earnings results on Feb 26, 2026. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is Rua Bioscience Ltd. overvalued?
According to Wall Street analysts Rua Bioscience Ltd.’s price is currently Undervalued.
Does Rua Bioscience Ltd. pay dividends?
Rua Bioscience Ltd. does not currently pay dividends.
What is Rua Bioscience Ltd.’s EPS estimate?
Rua Bioscience Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rua Bioscience Ltd. have?
Rua Bioscience Ltd. has 339,441,700 shares outstanding.
What happened to Rua Bioscience Ltd.’s price movement after its last earnings report?
Rua Bioscience Ltd. reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rua Bioscience Ltd.?
Currently, no hedge funds are holding shares in NZ:RUA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rua Bioscience Ltd.
Rua Bioscience Limited, a company founded in 2016 and headquartered in Gisborne, New Zealand, is dedicated to the investigation, refinement, and production of medicinal products for both the New Zealand market and international distribution. Their offerings primarily include pharmaceuticals developed from cannabinoids. The firm officially changed its name to Rua Bioscience Limited in October 2019, having previously been known as Hikurangi Cannabis Company Limited.
Technical Analysis
AFT Pharmaceuticals Ltd.
―
BLIS Technologies Limited
―
Vital Limited
―
Promisia Healthcare Limited
―
Third Age Health Services Limited
―